Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.

Neurophysiologie clinique = Clinical neurophysiology - 1 Oct 2001

Thobois S, Guillouet S, Broussolle E

Abstract excerpt

Positron emission tomography (PET) and single photon emission computed tomography (SPECT) provide the means to studying in vivo the neurochemical, hemodynamic or metabolic consequences of the degeneration of the nigrostriatal dopaminergic system in Parkinson's disease (PD). The extent of striatal dopaminergic denervation can be quantified with radiotracers as [18F]FDopa for PET and [123I]tropanes for SPECT. There...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiparkinson Agents
Share to Brain Tissue Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dihydroxyphenylalanine

Share to Dopamine Agonists

Share to Fetal Tissue Transplantation

Share to Iatrogenic Disease

Share to Parkinson Disease, Secondary

Share to Tomography, Emission-Computed

Source

Identifiers

PMID: 11817273
DOI: 10.1016/s0987-7053(01)00273-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.PMID 11817273Read ↗

[Nuclear medicine imaging in patients with Parkinson's syndrome: an update].Semantic proximity Read ↗

In vivo assessment of non-dopaminergic systems in Parkinson's disease with Positron Emission TomographySemantic proximity Read ↗

Extrastriatal SPECT-DAT uptake correlates with clinical and biological features of de novo Parkinson's disease.Semantic proximity Read ↗

[Imaging of genetic aspects of Parkinson's disease].Semantic proximity Read ↗

Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation.Semantic proximity Read ↗

Comparison of 18F-DOPA and 18F-DTBZ for PET/CT Imaging of Idiopathic Parkinson’s DiseaseSemantic proximity Read ↗

Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene.Semantic proximity Read ↗

An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.Semantic proximity Read ↗

Dual Biomarker Potential of 18F-PR04.MZ-PET: Assessing Dopaminergic Function and Cerebral Blood Flow in Degenerative Parkinsonian SyndromesSemantic proximity Read ↗

Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson’s disease patients with impulse control disordersSemantic proximity Read ↗

Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease.Semantic proximity Read ↗

Changes of “brain-GI” interplay in Parkinson’s disease: a pilot study of dynamic total-body [11C]CFT PET/CT and kinetic modelingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.